Detalhe da pesquisa
1.
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid.
Liver Int
; 42(11): 2453-2465, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35932095
2.
Rate of non-response to ursodeoxycholic acid in a large real-world cohort of primary biliary cholangitis patients in Italy.
Scand J Gastroenterol
; 54(10): 1274-1282, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31564176
3.
Clinical outcomes with long-term sorafenib treatment of patients with hepatocellular carcinoma: a multicenter real-life study.
Future Oncol
; 14(29): 3049-3058, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30091371
4.
[Therapeutic decisions and treatment with sorafenib in hepatocellular carcinoma: final analysis of GIDEON study in Italy]. / Scelte terapeutiche e trattamento con sorafenib nell'epatocarcinoma: analisi finale dello studio GIDEON in Italia.
Recenti Prog Med
; 106(5): 217-26, 2015 May.
Artigo
em Italiano
| MEDLINE | ID: mdl-25994538
5.
The double-sided of human leukocyte antigen-G molecules in type 1 autoimmune hepatitis.
Front Immunol
; 13: 1007647, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36311782
6.
Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis.
PLoS One
; 11(1): e0146086, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26744892
7.
Cytomegalovirus infection after liver transplantation: viral load as a guide to treating clinical infection.
Transplantation
; 74(4): 527-31, 2002 Aug 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-12352913
8.
An evaluation of long-term outcomes after liver transplantation for cryptogenic cirrhosis.
Liver Transpl
; 9(9): 921-8, 2003 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-12942453